Page 109 - Glucose Monitoring Devices

108 CHAPTER 5 Modeling the SMBG measurement error

[40] Vettoretti M, Facchinetti A, Sparacino G, Cobelli C. A model of self-monitoring blood
glucose measurement error. Journal of Diabetes Science and Technology 2017;11(4):
724e35.
[41] Vettoretti M, Facchinetti A, Sparacino G, Cobelli C. Accuracy of devices for self-
monitoring of blood glucose: a stochastic error model. Conference Proceedings IEEE
Engineering in Medicine and Biology Society 2015;2015:2359e62.
[42] Campos-Na ´n ˜ez E, Fortwaengler K, Breton MD. Clinical impact of blood glucose moni-
toring accuracy: an in-silico study. Journal of Diabetes Science and Technology 2017;
11(6):1187e95.
[43] Azzalini A. The skew-normal distribution and related multivariate families. Scandina-
vian Journal of Statistics 2005;32(2):159e88.
[44] Christiansen M, Bailey T, Watkins E, Liljenquist D, Price D, Nakamura K, et al. A new-
generation continuous glucose monitoring system: improved accuracy and reliability
compared with a previous-generation system. Diabetes Technology and Therapeutics
2013;15(10):1e8.
[45] De Nicolao G, Sparacino G, Cobelli C. Nonparametric input estimation in physiological
systems: problems, methods and case studies. Automatica 1997;33(5):851e70.
[46] YSI life sciences. User’s manual YSI 2300 STAT PLUS. 2009. Available from: https://
www.ysi.com/File%20Library/Documents/Manuals%20for%20Discontinued%
20Products/YSI-2300-Stat-Plus-manual-j.pdf. [Accessed 9 January 2019].
[47] Bailey TS, Chang A, Christiansen M. Clinical accuracy of a continuous glucose moni-
toring system with an advanced algorithm. Journal of Diabetes Science and Technology
2015;9(2):209e14.
[48] Garcı ´a-Jaramillo M, Calm R, Bondia J, Tarı ´n C, Vehı ´ J. Insulin dosage optimization
based on prediction of postprandial glucose excursions under uncertain parameters
and food intake. Computer Methods and Programs in Biomedicine 2012;105(1):61e9.
[49] Wang Z, Paranjape R. A signal processing application for evaluating self-monitoring
blood glucose strategies in a software agent model. Computer Methods and Programs
in Biomedicine 2015;120(2):77e87.
[50] Vettoretti M, Facchinetti A, Sparacino G, Cobelli C. Type-1 diabetes patient decision
simulator for in silico testing safety and effectiveness of insulin treatments. IEEE Trans-
actions on Biomedical Engineering 2018;65(6):1281e90.
[51] Vettoretti M, Facchinetti A, Sparacino G, Cobelli C. Patient decision-making of CGM
sensor driven insulin therapies in type 1 diabetes: in silico assessment. Conference Pro-
ceedings IEEE Engineering in Medicine and Biology Society 2015;2015:2363e6.
[52] Facchinetti A. Continuous glucose monitoring sensors: past, present and future algo-
rithmic challenges. Sensors 2016;16(12):E2093.
[53] FDA advisory panel votes to recommend non-adjunctive use of Dexcom G5 Mobile
CGM. Diabetes Technology and Therapeutics 2016;18:512e6.
[54] Edelman SV. Regulation catches up to reality: nonadjunctive use of continuous glucose
monitoring data. Journal of Diabetes Science and Technology 2017;11(1):160e4.
[55] CGM rulings. Ruling No. [CMS-1682-R]. Centers for medicare & medicaid services.
2017. Available from: www.cms.gov/Regulations-and-Guidance/Guidance/Rulings/
Downloads/CMS1682R.pdf. [Accessed 7 January 2019].
[56] Vettoretti M, Cappon G, Acciaroli G, Facchinetti A, Sparacino G. Continuous glucose
monitoring: current use in diabetes management and possible future applications. Jour-
nal of Diabetes Science and Technology 2018;12(5):1064e71.